ncs-import
Sunday, November 13, 2011
PDL Biopharma of Incline Village reported last week that it earned $45.9 million in the third quarter, which compares with earnings of $40.2 million in the comparable quarter last year.
The company owns a portfolio of patent and royalty interests.
Use the comment form below to begin a discussion about this content.
Username
Password Forgot?
Sign in
Password
Confirm password
Email
Sign up
November 4, 2024 7 a.m.
November 4, 2024 6:30 a.m.
November 4, 2024 6:15 a.m.
November 1, 2024 7 a.m.
November 1, 2024 6:45 a.m.
Comments
Use the comment form below to begin a discussion about this content.
Sign in to comment